Article
Computational design of SARS-CoV-2 spike glycoproteins to increase immunogenicity by T cell epitope engineering
30 Dec 2020
Abstract excerpt
The development of effective and safe vaccines is the ultimate way to efficiently stop the ongoing COVID-19 pandemic, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Built on the fact that SARS-CoV-2 utilizes the association of its Spike (S) protein with the human angiotensin-converting enzyme 2 (ACE2) receptor to invade host cells, we computationally redesigned the S protein...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
